Clinical TrialsSearch results
Number of results: 701
Other
- Effect of Meniett device on clinical symptoms in patients with endolymphatic hydrops
- endolymphatic hydrops
- Dept. of Otolaryngology, University of Toyama
- 2009-08-31
Other
- Phase 3 study of pembrolizumab vs chemotherapy in dMMR advanced or recurrent endometrial carcinoma
- Endometrial cancer
- Hoki Toshifumi
- 2022-01-30
Other
- Japan endometrioma malignant transformation study
- endometriosis
- Japan Society of Obstetrics and Gynecology
- 2009-04-13
Completed
- A study of FSN-013 in Japanese patients with endometriosis
- endometriosis
- Takayanagi Toshiaki
- 2021-08-06
Other
- A Phase III, Double-blind, Randomised Study to Assess Switching to AZD9833 (a Next Generation, Oral SERD) + CDK4/6 Inhibitor vs Continuing Aromatase Inhibitor (Letrozole or Anastrozole)+ CDK4/6 Inhibitor in HR+/HER2-MBC Patients With Detectable ESR1Mutation Without Disease Progression During 1L Treatment With Aromatase Inhibitor+ CDK4/6 Inhibitor- A ctDNA Guided Early Switch Study
- ER-Positive HER2-Negative Breast Cancer
- Hibi Kazusihge
- 2021-09-07
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Other
- The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
- Essential hypertension
- JATOS Study Group
- 2008-02-15
Other
- Japan Home versus Office Measurement Evaluation for Heart Rate study
- Essential Hypertension
- Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
- 2008-08-01
Other
- Gene evaluation for antihypertensive drug effects study
- essential hypertension
- National Cardiovascular Center
- 2005-09-07
Other
- phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer.
- extensive disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-05